NEWS BLOG

Annual meeting of the European Tissue Repair Society (ETRS) and Portuguese Society of Stem Cells and Cell Therapies (SPCE), October 2023.

The prestigious Johann Georg Zimmermann Medal was awarded this year to LIT scientist Prof. Dr. Hinrich Abken.

This award has been created to recognise individuals for their outstanding contribution to ESGCT and their commitment to Society’s...

This new award has been created to recognise individuals for their outstanding contribution to ESGCT's mission to advance knowledge.

OCTOBER 23, 2023 BRUSSELS, BELGIUM The Transatlantic Gene Therapy Consortium gladly invites you to join us at the 13th Stem Cell...

It is with great pleasure that the board of the ESGCT confers to professor Seppo Yla-Herttuala the award to his outstanding career....

The candidate will be involved in projects that aim to develop genome editing strategies for treatment of retinal and metabolic diseases.

Pfizer Global Medical Grants have opened a request for proposals that advance our understanding of Duchenne muscular dystrophy.

November 8-10, 2023, Rotterdam.

The World Anti-Doping Agency (WADA) is pleased to inform you of a call for research projects on the theme of Gene Doping Detection that...

SFTCG's next webinar series begins on 10 February with 'An introduction to gene editing for gene therapy applications'.

View a summary of our headline numbers and achievements in 2022.

See how the BME Paris Master's Programme students have benefitted from ESGCT activities!

Ami Patel, Daniel Lucey and Dong-Yan Jin.

Laura Sepp-Lorenzino, Toni Cathomen and Virgis Siksnys. Series supported by Intellia Therapeutics.

Saul Priceman, Dimitrios Wagner and Marco Alessandrini. Series in collaboration with the American Society of Gene & Cell Therapy.

This INTERNATIONAL Call for Proposals, open to both French and foreign teams.

ESGCT members are invited to send their news items to share via our website and social media.

Thierry VandenDriessche(1), Steven W Pipe(2), Glenn F Pierce(3), Radoslaw Kaczmarek(4) 1. Department of Gene Therapy & Regenerative...

A new Europe-wide academic initiative, named AGORA (Access to Gene therapies fOr RAre disease), has been launched.